BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2507819)

  • 61. Effectiveness of ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium, and rifampin against M. tuberculosis in cultured human macrophages.
    Crowle AJ; Elkins N; May MH
    Am Rev Respir Dis; 1988 May; 137(5):1141-6. PubMed ID: 3143278
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chlorpromazine: a drug potentially useful for treating mycobacterial infections.
    Crowle AJ; Douvas GS; May MH
    Chemotherapy; 1992; 38(6):410-9. PubMed ID: 1288966
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Oxazolidinones, a new class of synthetic antituberculosis agent. In vitro and in vivo activities of DuP-721 against Mycobacterium tuberculosis.
    Ashtekar DR; Costa-Periera R; Shrinivasan T; Iyyer R; Vishvanathan N; Rittel W
    Diagn Microbiol Infect Dis; 1991; 14(6):465-71. PubMed ID: 1802533
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Drug resistance profile of human Mycobacterium avium complex strains from India.
    Venugopal D; Kumar S; Isa M; Bose M
    Indian J Med Microbiol; 2007 Apr; 25(2):115-20. PubMed ID: 17582180
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Correlations among naturally occurring resistances to antituberculosis drugs in Mycobacterium avium complex strains.
    Tsukamura M; Miyachi T
    Am Rev Respir Dis; 1989 Apr; 139(4):1033-5. PubMed ID: 2930064
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Different correlations of drug susceptibilities to colonial morphology in Mycobacterium avium complex strains.
    Tsukamura M; Mizuno S; Miyama A
    Microbiol Immunol; 1989; 33(12):1001-11. PubMed ID: 2622394
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antituberculosis activity of certain antifungal and antihelmintic drugs.
    Sun Z; Zhang Y
    Tuber Lung Dis; 1999; 79(5):319-20. PubMed ID: 10707260
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In-vitro bacteriostatic and bactericidal activity of isoniazid on the Mycobacterium avium-Mycobacterium intracellulare complex.
    Tsukamura M
    Tubercle; 1990 Sep; 71(3):199-204. PubMed ID: 2238126
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A radiometric method for predicting effectiveness of chemotherapeutic agents in murine leprosy.
    Camargo EE; Larson SM; Tepper BS; Wagner HN
    Int J Lepr Other Mycobact Dis; 1975; 43(3):234-8. PubMed ID: 176120
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium.
    Heifets LB; Lindholm-Levy PJ; Comstock RD
    Am Rev Respir Dis; 1992 Apr; 145(4 Pt 1):856-8. PubMed ID: 1532486
    [TBL] [Abstract][Full Text] [Related]  

  • 71. JVA, an isoniazid analogue, is a bioactive compound against a clinical isolate of the Mycobacterium avium complex.
    Fahel JS; Vieira RP; Marinho FV; Santos VC; de Assis JV; Corsetti PP; Ferreira RS; de Almeida MV; Oliveira SC
    Tuberculosis (Edinb); 2019 Mar; 115():108-112. PubMed ID: 30948164
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Activity of 2-acetylpyridine and 2-acetylquinoline thiosemicarbazones tested in vitro in combination with other antituberculous drugs.
    Collins FM; Klayman DL; Morrison NE
    Am Rev Respir Dis; 1982 Jan; 125(1):58-60. PubMed ID: 6175259
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Microcalorimetric studies of the initial interaction between antimycobacterial drugs and Mycobacterium avium.
    Hoffner SE; Svenson SB; Beezer AE
    J Antimicrob Chemother; 1990 Mar; 25(3):353-9. PubMed ID: 2338413
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Bactericidal activity of ofloxacin against Mycobacterium kansasii].
    Tsukamura M
    Kekkaku; 1990 Nov; 65(11):719-21. PubMed ID: 2277465
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ciprofloxacin susceptibility testing by MIC and disk elution of drug-resistant Mycobacterium tuberculosis and Mycobacterium avium complex.
    LaBombardi VJ; Cataldo-Caputzal L
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1556-7. PubMed ID: 8363391
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Postantibiotic effect of amikacin and rifapentine against Mycobacterium avium complex.
    Bermudez LE; Wu M; Young LS; Inderlied CB
    J Infect Dis; 1992 Oct; 166(4):923-6. PubMed ID: 1445599
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Glycosyltransferases as targets for inhibition of cell wall synthesis in M. tuberculosis and M. avium.
    Maddry JA; Suling WJ; Reynolds RC
    Res Microbiol; 1996; 147(1-2):106-12. PubMed ID: 8761730
    [No Abstract]   [Full Text] [Related]  

  • 78. Effect of Tween 80 on the growth of Mycobacterium avium complex.
    Masaki S; Sugimori G; Okamoto A; Imose J; Hayashi Y
    Microbiol Immunol; 1990; 34(8):653-63. PubMed ID: 2280723
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Qualitative and quantitative drug-susceptibility tests in mycobacteriology.
    Heifets L
    Am Rev Respir Dis; 1988 May; 137(5):1217-22. PubMed ID: 3195815
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clofazimine and other rimino-compounds: minimal inhibitory and minimal bactericidal concentrations at different pHs for Mycobacterium avium complex.
    Lindholm-Levy PJ; Heifets LB
    Tubercle; 1988 Sep; 69(3):179-86. PubMed ID: 3254636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.